New FDA Enforcement Stats Show Shifting Targets

Law360, New York (February 13, 2017, 8:41 PM EST) -- Newly released statistics from the U.S. Food and Drug Administration show that enforcement was busier in 2016 for pharmaceuticals but was relatively quiet for medical devices, tobacco and biologics.

FDA officials quietly published the annual numbers late last week, detailing the number of warning letters and recalls targeting FDA-regulated industries. The numbers — which don't include previously disclosed 2016 data from the FDA's Office of Prescription Drug Promotion —  weren't accompanied by any explanatory text. Agency representatives had little comment, so Law360 surveyed experts for insights...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.